Safety and Immunogenicity of an A (H1N1) 2009 Influenza Virus-like Particle (VLP) Vaccine

NCT01072799 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

4560

Enrollment

INDUSTRY

Sponsor class

Conditions

Seasonal Influenza

Interventions

BIOLOGICAL: Placebo
BIOLOGICAL: A/H1N1 2009 Influenza VLP Vaccine

Sponsor

Novavax

Collaborators

[object Object]